Savara Pharmaceuticals
SVRA
$4.09
Share price
-0.49%
Change (1 day)
39.59%
Change (1 year)
Categories
Savara Pharmaceuticals (SVRA) - Total debt
Total debt on the balance sheet as of March 2024 : $26.56 M
According to Savara Pharmaceuticals's latest financial reports the company's total debt is $26.56 M. A company’s total debt is the sum of all current and non-current debts.
Savara Pharmaceuticals - Total debt on balance sheet (from 2002 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $26.49 M | 1.34% |
| 2022-12-31 | $26.14 M | 1.36% |
| 2021-12-31 | $25.79 M | 2.01% |
| 2020-12-31 | $25.28 M | -1.05% |
| 2019-12-31 | $25.55 M | 3.99% |
| 2018-12-31 | $24.57 M | 60.21% |
| 2017-12-31 | $15.33 M | 243.19% |
| 2016-12-31 | $4.46 M | -69.69% |
| 2015-12-31 | $14.74 M | |
| 2002-12-31 | $0.25 M | 366.48% |
| 2001-12-31 | $0.05 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.41 B | 1,479.55% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |